Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stemgen + Filgrastim vs Filgrastim for Stem Cell Mobilization in Multiple Myeloma
NCT00001750Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Sep 1998
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of ancestim in multiple myeloma (MM), sponsored by National Heart, Lung, and Blood Institute. Started Sep 1998; status: completed.
02
Drugs
ancestim
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00001750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001750.